Firstly, antitumor active platinum compounds enter tumour cells through passive diffusion and transport proteins, including organic cation transporter OCT1-3 (organic cation transporter 1–3) and copper-transporter 1 (CTR1). The gene discussed is SLC31A1; the disease is neoplasm.